<PAGE>
Exhibit 23.2
--------------------------------------------------------------------------------
Consent of KPMG LLP
The Board of Directors
ThermoGen, Inc.:
We consent to the inclusion of our report dated March 21, 2000, with respect to
the balance sheets of ThermoGen, Inc. as of December 31, 1998 and 1999, and the
related statements of operations, shareholders' deficit, and cash flows for
each of the years in the two-year period ended December 31, 1999, which report
appears in the registration statement (No. 333-39548) on Form S-1 of MediChem
Life Sciences, Inc., and to the reference to our firm under the heading
"Experts" in the prospectus.
Our report dated March 21, 2000, contains an explanatory paragraph that states
that the Company has suffered recurring losses from operations that raise
substantial doubt about its ability to continue as a going concern. The
financial statements do not include any adjustments that might result from the
outcome of that uncertainty.
/s/ KPMG LLP
Chicago, Illinois
October 2, 2000
